Menu Search
Equities

Orpea SA

ORPN:MEX

Orpea SA

Actions
  • Price (MXN)177.03
  • Today's Change-57.91 / -24.65%
  • Shares traded-1.00
  • 1 Year change-99.67%
  • Beta--
Data delayed at least 20 minutes, as of Sep 14 2022 12:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Orpea SA is a France-based company that is engaged in the operations of retirement homes, outpatient and rehabilitation clinics, and psychiatric care. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services, and long-term care homes. The Company operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. It operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.

  • Revenue in EUR (TTM)--
  • Net income in EUR--
  • Incorporated1995
  • Employees76.16k
  • Location
    Orpea SA12 Rue Jean Jaures, Puteaux CedexPUTEAUX 92813FranceFRA
  • Phone+33 147757807
  • Fax+33 147757799
  • Websitehttps://www.orpea.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.